Sigma Planning Corp’s Alpha Tau Medical DRTS Stock Holding History

Sigma Planning Corp’s Portfolio DRTS Stock Details DRTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$151K	Buy	+10,100	New	+$139K	﹤0.01%	1280

Other funds holding DRTS

Apella Capital West Hartford, Connecticut $7.88B AUM 10.78% 1-Year Est. Return

Daytona Street Capital Saint Louis, Missouri $141M AUM 14.38% 1-Year Est. Return

Woodstock Corp Boston, Massachusetts $1.24B AUM 22.02% 1-Year Est. Return

Financial Guidance Group Palm Harbor, Florida $279M AUM 14.19% 1-Year Est. Return

Opal Wealth Advisors Jericho, New York $479M AUM 15.43% 1-Year Est. Return

Tower View Wealth Management Shorewood, Wisconsin $231M AUM 32.95% 1-Year Est. Return

TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return

PWMG

Private Wealth Management Group Princeton, New Jersey $445M AUM 13.54% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Sigma Planning Corp's DRTS Position: Q3 2026 in Review

Sigma Planning Corp opened a new position in Alpha Tau Medical (DRTS) in Q3 2026: 10,100 shares worth $151K. The stake represents ﹤0.01% of the portfolio and ranks #1280 among its holdings.

14 funds tracked by Wall St. Rank hold DRTS as of Q3 2026.

Sigma Planning Corp held 10,100 shares of Alpha Tau Medical worth $151K as of Q3 2026.
Alpha Tau Medical was a new Sigma Planning Corp position in Q3 2026.
Alpha Tau Medical made up ﹤0.01% of Sigma Planning Corp's portfolio in Q3 2026, its #1280 holding.
14 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q3 2026.

Based on Sigma Planning Corp's 13F filing for Q3 2026, filed 23 Oct 2026.